KALA BIO, Inc. (KALA)
NASDAQ: KALA · Real-Time Price · USD
0.4133
-0.0017 (-0.41%)
Feb 10, 2026, 1:39 PM EST - Market open

KALA BIO Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
1233196179380
Market Cap Growth
-68.78%74.89%-69.02%-23.21%-79.15%198.27%
Enterprise Value
2121-15162322
Last Close Price
0.416.947.0038.1560.50339.00
PS Ratio
---15.647.0559.76
PB Ratio
-2.672.513.214.723.80
P/TBV Ratio
-2.672.513.214.723.80
EV/Sales Ratio
---13.105.5050.62
Debt / Equity Ratio
-3.462.624.842.264.771.01
Asset Turnover
---0.030.060.03
Inventory Turnover
----0.590.54
Quick Ratio
0.653.026.102.792.957.38
Current Ratio
0.753.116.343.353.327.71
Return on Equity (ROE)
--388.29%-318.75%-250.56%-244.19%-160.89%
Return on Assets (ROA)
-65.81%-45.36%-34.28%-44.95%-37.89%-31.83%
Return on Capital Employed (ROCE)
551.30%-104.90%-82.20%-133.10%-107.30%-48.00%
Earnings Yield
-305.72%-116.81%-223.85%-73.65%-179.93%-27.44%
FCF Yield
-273.95%-89.75%-151.38%-130.17%-137.68%-24.37%
Buyback Yield / Dilution
-86.46%-56.09%-59.94%-15.50%-25.67%-53.11%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q